Compare ASTRAZENECA PHARMA with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ALEMBIC PHARMA - Comparison Results

ASTRAZENECA PHARMA     Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA ALEMBIC PHARMA ASTRAZENECA PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x 118.5 22.0 537.9% View Chart
P/BV x 34.7 6.5 531.3% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ASTRAZENECA PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-18
ALEMBIC PHARMA
Mar-19
ASTRAZENECA PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs1,278664 192.5%   
Low Rs883412 214.0%   
Sales per share (Unadj.) Rs228.4208.7 109.4%  
Earnings per share (Unadj.) Rs10.431.0 33.4%  
Cash flow per share (Unadj.) Rs16.337.1 43.8%  
Dividends per share (Unadj.) Rs05.50 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs98.8144.2 68.5%  
Shares outstanding (eoy) m25.00188.52 13.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.72.6 183.4%   
Avg P/E ratio x104.217.4 600.3%  
P/CF ratio (eoy) x66.414.5 458.1%  
Price / Book Value ratio x10.93.7 293.1%  
Dividend payout %017.7 0.0%   
Avg Mkt Cap Rs m27,008101,461 26.6%   
No. of employees `0001.4NA-   
Total wages/salary Rs m1,5357,467 20.6%   
Avg. sales/employee Rs Th4,210.9NM-  
Avg. wages/employee Rs Th1,132.2NM-  
Avg. net profit/employee Rs Th191.1NM-  
INCOME DATA
Net Sales Rs m5,71039,347 14.5%  
Other income Rs m12394 130.6%   
Total revenues Rs m5,83339,441 14.8%   
Gross profit Rs m4638,736 5.3%  
Depreciation Rs m1471,152 12.8%   
Interest Rs m0184 0.0%   
Profit before tax Rs m4387,493 5.8%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1791,568 11.4%   
Profit after tax Rs m2595,844 4.4%  
Gross profit margin %8.122.2 36.5%  
Effective tax rate %40.820.9 195.3%   
Net profit margin %4.514.9 30.6%  
BALANCE SHEET DATA
Current assets Rs m3,20919,577 16.4%   
Current liabilities Rs m2,07014,896 13.9%   
Net working cap to sales %20.011.9 167.8%  
Current ratio x1.61.3 118.0%  
Inventory Days Days7290 80.6%  
Debtors Days Days3545 77.0%  
Net fixed assets Rs m79027,097 2.9%   
Share capital Rs m50377 13.3%   
"Free" reserves Rs m2,41926,811 9.0%   
Net worth Rs m2,46927,188 9.1%   
Long term debt Rs m04,993 0.0%   
Total assets Rs m4,60547,778 9.6%  
Interest coverage xNM41.7-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.20.8 150.6%   
Return on assets %5.612.6 44.6%  
Return on equity %10.521.5 48.8%  
Return on capital %17.723.6 75.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m30019,453 1.5%   
Fx outflow Rs m2,0156,065 33.2%   
Net fx Rs m-1,71513,388 -12.8%   
CASH FLOW
From Operations Rs m888,120 1.1%  
From Investments Rs m-94-7,556 1.2%  
From Financial Activity Rs mNA590 0.0%  
Net Cashflow Rs m-61,153 -0.5%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 0.3 2.9 10.3%  
FIIs % 15.7 9.1 172.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 9.1 13.9 65.5%  
Shareholders   12,856 49,328 26.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   PIRAMAL ENTERPRISES  NOVARTIS  FRESENIUS KABI ONCO.  DR. REDDYS LAB  GSK PHARMA  

Compare ASTRAZENECA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 143 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day today, tracking weak global cues as coronavirus cases continue to surge across the world.

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium(Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Jul 10, 2020 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 5-YR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS